<DOC>
	<DOCNO>NCT02757456</DOCNO>
	<brief_summary>Arterial calcification common incident hemodialysis population , range 71-83 % .Given cardiovascular disease major cause mortality hemodialysis population , medial arterial calcification may contribute increase risk sudden death congestive heart failure . Applanation tonometry method choice measure pulse wave velocity pulse wave analysis . The primary objective ass effect 16 week exercise program aortic pulse wave velocity vascular parameter gait speed physical functioning parameter . The secondary objective assess effect exercise program ultrafiltration rate , weight , SBP , DBP , BNP , hsTroponin , serum calcium , phosphate , albumin , glucose , LDL , HDL , TG , glycated hemoglobin , hemoglobin , CRP , micro RNAs ( 21 , 126 , 133 , 146a , 221/222 210 ) hospitalization .</brief_summary>
	<brief_title>Exercise Vascular Parameters Hemodialysis</brief_title>
	<detailed_description>The investigator propose pilot project assess effect 16 week aerobic exercise program arterial stiffness cardiovascular risk hemodialysis population . The primary objective ass effect 16 week exercise program aortic pulse wave velocity vascular parameter gait speed physical functioning parameter . The secondary objective assess effect exercise program ultrafiltration rate , weight , SBP , DBP , BNP , hsTroponin , serum calcium , phosphate , albumin , glucose , LDL , HDL , TG , glycated hemoglobin , hemoglobin , CRP , micro RNAs ( 21 , 126 , 133 , 146a , 221/222 210 ) hospitalization . Study Design : Randomized-controlled study end stage renal disease patient age 18 90 year assess effect exercise arterial stiffness . Our aim 23 patient group . The study period 24 weeks—4 week recruitment , 16 week intervention 4 week data collection analysis . The protocol submit MUHC Research Ethics Board . The following outcomes interest : 1. change gait speed exercise program 2. change pulse wave velocity exercise program 3. change BNP , blood pressure , dialysis ultrafiltration , hemoglobin , micro RNAs exercise program</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<criteria>1 . Male female , age 1895 year 2 . Able comply study procedure medication 3 . Written informed consent give 4 . On stable incenter hemodialysis regimen ( least 3 time per week ) ≥ 12 week prior recruitment 5 . Cardiac evaluation within year adequate cardiac function able undergo exercise program 1 . Participation clinical trial use investigational product device 30 day precede recruitment 2 . Any physical psychological disability would impact study participation , severe cerebrovascular disease ( ie . hemiparesis , cerebellar ataxia , etc . ) dementia 3 . Serum iPTH &gt; 250 pmol/L within 30 day prior screen visit 4 . Dysrhythmia severe cardiac disease : CHF Class IIIIV ; unstable cardiovascular diagnosis ( example MI , CABG , PTCA , CVA , TIA ) within 90 day prior recruitment 5 . Severe peripheral vascular disease 6 . Severe hyperkalemia ( &gt; 6.5 mmol/L ) consistently last 2 week 7 . Current active cancer ( exclude basal cell carcinoma skin ) 8 . Poorly control hypertension ( systolic &gt; 180mmHg diastolic &gt; 100mmHg ) within 4 week prior recruitment 9 . Anticipated live donor kidney transplant plan major surgery study duration 10 . History poor adherence hemodialysis medical regimen 11 . Any disease condition , physical psychological , opinion investigator , would compromise safety subject likelihood achieve reliable result increase likelihood subject withdrawn</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>exercise</keyword>
	<keyword>hemodialysis</keyword>
	<keyword>pulse wave velocity</keyword>
	<keyword>micro RNAs</keyword>
</DOC>